Medtronic (NYSE:MDT) launched its newest drug-eluting coronary stent, Onyx Frontier.

The Fridley, Minnesota-based company designed the Onyx Frontier drug-eluting stent (DES) to build upon its Resolute Onyx DES. It uses the same stent platform as the Resolute Onyx and has an enhanced delivery system to increase acute performance in interventional coronary artery disease procedures.

Get the full story at our sister site, Medical Tubing & Extrusion.